Hiroaki Satoh

Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non–Small-Cell Lung Cancer Patients

H. Satoh, H. Ohtani, Ryota Nakamura, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Squamous Cell Carcinoma Antigen in Lung Cancer and Nonmalignant Respiratory Diseases

H. Satoh, M. Ohtsuka, K. Sekizawa, 2008, Lung.

Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report.

Tadashi Kondo, H. Satoh, T. Kondo, 2015, Experimental and therapeutic medicine.

Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba.

Shinji Sugahara, Koji Tsuboi, Koichi Tokuuye, 2010, International journal of radiation oncology, biology, physics.

Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.

Iwao Yamaguchi, Nobuyuki Hizawa, H. Satoh, 2012, Oncology letters.

Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: distinguishing influence of exon 19 deletion on radiographic features.

Takashi Ogura, Tomotaka Kasamatsu, Katsumi Tamura, 2012, Lung cancer.

Prognostic value of tumor disappearance rate on computed tomography in advanced-stage lung adenocarcinoma.

Norihiro Kikuchi, N. Kikuchi, H. Satoh, 2007, Clinical lung cancer.

Japanese lung cancer research trends and performance in Science Citation Index.

Yuh-Shan Ho, Y. Ho, H. Satoh, 2010, Internal medicine.

Application of conditional probability analysis to distant metastases from lung cancer.

H. Satoh, Hideto Takahashi, Hiroaki Satoh, 2012, Oncology letters.